Main Article Content


Background: Diabetes Mellitus is one of the risk factors for COVID-19. This causes the morbidity and severity of COVID-19 patients to be higher in patients with diabetes. Objectivity: This study aimed to determine the effectiveness of treatment therapy for COVID-19 patients with comorbid diabetes at the South Tangerang City General Hospital. Material and methods: This study used a descriptive design with a quantitative approach and retrospective data collection. Sampling was done by Total Sampling with a total sample of 127 patients from 234 patients. Result: The characteristics of COVID-19 patients with comorbid diabetes were dominated by the male gender (55.1%), with an age range of 46-55 years (38.6%), high school education (43.3%), and have a private employee type of work (55.1%). The symptoms of COVID-19 patients with comorbid diabetes were cough (89.8%), with a length of stay for patients 7–14 days (72.4%).Treatment for COVID-19 with comorbid diabetes was antibiotics azithromycin (26.0%), antiviral remdesivir (62.2%), methylprednisolone (73.2%), acetylcysteine (85.0%), vitamin C (89.8%), and the antidiabetic group that is often used is insulin novorapid (41.7%). Conclusion: The results of laboratory examinations showed that COVID-19 treatment therapy is effective in reducing the amount of virus in the blood, which is indicated by an increase in the PCR value (p-value <0.001), lowering blood sugar levels (which is characterized by a decrease in blood sugar levels when (p-value <0.001) ), and reduce hypercoagulation which is characterized by a reduction in the value of D-dimer (p-value < 0.005).


COVID-19 Remdisivir Diabetes Mellitus Novorapid Acute Respiratory Distress Syndrome

Article Details

How to Cite
Hasanah, N., Ismaya, N. A., Tulandi, S. M., Permatasari, P. I., Wafa, W., & Hakim, A. N. (2023). COVID-19 and Diabetes Mellitus at RSU South Tangerang-Indonesia: Clinical Profile and Treatment Strategies: COVID-19 dan Diabetes Mellitus di RSU Tangerang Selatan-Indonesia: Profil Klinis dan strategi pengobatan. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal), 9(2), 119-131.


  1. Journal Article
  2. Baihaqi, F. A., & Rumaropen, H. (2022). Faktor-Faktor yang Berhubungan dengan Lama Rawat Inap Pasien COVID-19 di RSUD Serui Provinsi Papua: Studi Potong Lintang. Jurnal Penyakit Dalam Indonesia, 8(4), 187.
  3. Bozkaya, G., Uzuncan, N., Bilgili, S., & Demirezen, O. (2019). Evaluation of analytical performance of Variant II Turbo HbA1c analyzer according to sigma metrics. Journal of Medical Biochemistry, 38(1), 33–37.
  4. Bravi, F., Flacco, M. E., Carradori, T., Volta, C. A., Cosenza, G., De Togni, A., Martellucci, C. A., Parruti, G., Mantovani, L., & Manzoli, L. (2020). Predictors of severe or lethal COVID-19, including angiotensin converting enzyme inhibitors and angiotensin II receptor blockers, in a sample of infected Italian citizens. PLoS ONE, 15(6 June), 1–10.
  5. Chen, J., Wu, C., Wang, X., Yu, J., & Sun, Z. (2020). The Impact of COVID-19 on Blood Glucose: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology, 11(October), 1–8.
  6. Chikovore, J., Pai, M., Horton, K. C., Daftary, A., Kumwenda, M. K., Hart, G., & Corbett, E. L. (2020). Missing men with tuberculosis: the need to address structural influences and implement targeted and multidimensional interventions. BMJ Global Health, 5(5), e002255.
  7. Datta, C., & Bhattacharjee, A. (2020). Cytokine Storm and its Implication in Coronavirus disease 2019 (COVID-19). Journal of Immunological Sciences, 4(3), 4–21.
  8. Dessie, A. M., Feleke, S. F., Anley, D. T., Anteneh, R. M., & Demissie, Z. A. (2022). Assessment of Factors Affecting Time to Recovery from COVID-19: A Retrospective Study in Ethiopia. Advances in Public Health, 2022.
  9. El Chakhtoura, N. G., Bonomo, R. A., & Jump, R. L. P. (2017). Influence of Aging and Environment on Presentation of Infection in Older Adults. Infectious Disease Clinics of North America, 31(4), 593–608.
  10. Evans, M., Wilkinson, M., & Giannpolou, A. (2019). Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin. Diabetes Therapy, 10(5), 1793–1800.
  11. Fitrian, N. I. (2020). Virologi, Patogenesis, Dan Manifestasi Klinis. Sustainability (Switzerland), 4(1), 1–9.
  12. Garavand, A., Mohseni, M., Asadi, H., Etemadi, M., Moradi-Joo, M., & Moosavi, A. (2016). Factors influencing the adoption of health information technologies: a systematic review. Electronic Physician, 8(8), 2713–2718.
  13. Hentsch, L., Cocetta, S., Allali, G., Santana, I., Eason, R., Adam, E., & Janssens, J. P. (2021). Breathlessness and COVID-19: A call for research. Respiration, 100(10), 1016–1026.
  14. Jomah, S., Asdaq, S. M. B., & Al-Yamani, M. J. (2020). Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review. Journal of Infection and Public Health, 13(9), 1187–1195.
  15. Khaerunnisa, R., Aula Rumana, N., Yulia, N., & Fannya, P. (2022). Gambaran Karakteristik Pasien Covid-19 di Rumah Sakit Mekar Sari Bekasi Tahun 2020-2021. Jurnal Manajemen Informasi Kesehatan Indonesia, 10(1), 64–72.
  16. Kichloo, A., Dettloff, K., Aljadah, M., Albosta, M., Jamal, S., Singh, J., Wani, F., Kumar, A., Vallabhaneni, S., & Khan, M. Z. (2020). COVID-19 and Hypercoagulability: A Review. Clinical and Applied Thrombosis/Hemostasis, 26.
  17. Koh, D. (2020). Occupational risks for COVID-19 infection. Occupational Medicine, 70(1), 3–5.
  18. Kokic, G., Hillen, H. S., Tegunov, D., Dienemann, C., Seitz, F., Schmitzova, J., Farnung, L., Siewert, A., Höbartner, C., & Cramer, P. (2021). Mechanism of SARS-CoV-2 polymerase stalling by remdesivir. Nature Communications, 12(1), 1–7.
  19. Lan, F. Y., Wei, C. F., Hsu, Y. T., Christiani, D. C., & Kales, S. N. (2020). Work-related COVID-19 transmission in six Asian countries/areas: A follow-up study. PLoS ONE, 15(5), 1–11.
  20. Lopes, P. C., Block, P., & König, B. (2016). Infection-induced behavioural changes reduce connectivity and the potential for disease spread in wild mice contact networks. Scientific Reports, 6(February), 1–10.
  21. Made Maharianingsih, N., Ketut Sudirta, I., Putu, N., Suryaningsih, A., Made, N., Program, M., & Farmasi, S. (2022). Karakteristik Pasien dan Penggunaan Obat Pada Pasien Covid-19 Derajat Sedang-Berat di RSUD Karangasem. Indonesian Journal of Pharmaceutical Education (e-Journal), 2(2), 86–94.
  22. Megyeri, K., Dernovics, Á., Al-Luhaibi, Z. I. I., & Rosztóczy, A. (2021). COVID-19-associated diarrhea. World Journal of Gastroenterology, 27(23), 3208–3222.
  23. Minuljo, T. T., Anindita, Y. P. C., Seno, H. N. H., Pemayun, T. G. D., & Sofro, M. A. U. (2020). Karakteristik dan Keluaran Pasien COVID-19 dengan DM di RS Umum Pusat Dr. Kariadi (Tinjauan pasien periode Maret-Juli 2020). Medica Hospitalia : Journal of Clinical Medicine, 7(1A), 150–158.
  24. Nieman, D. C., & Wentz, L. M. (2019). The compelling link between physical activity and the body’s defense system. Journal of Sport and Health Science, 8(3), 201–217.
  25. Ortona, Elena, M. P. and V. R. (2011). Sex Hormones and Gender Differences in Immune Responses. Ann Ist Super Sanità, 47(4), 363–372.
  26. Owora, A. H. (2018). Diagnostic Validity and Clinical Utility of HbA1c Tests for Type 2 Diabetes Mellitus. 196–199.
  27. Roeroe, P. A. L., Sedli, B. P., & Umboh, O. (2021). Faktor Risiko Terjadinya Coronavirus Disease 2019 (Covid-19) pada Penyandang Diabetes Melitus Tipe 2. E-CliniC, 9(1), 154–160.
  28. Ryde, G. C., Atkinson, P., Stead, M., Gorely, T., & Evans, J. M. M. (2020). Physical activity in paid work time for desk-based employees: A qualitative study of employers’ and employees’ perspectives. BMC Public Health, 20(1), 1–10.
  29. Setyaningsih, R., & Diyono, . (2020). Faktor-Faktor Yang Mempengaruhi Kejadian Diare Pada Balita. KOSALA : Jurnal Ilmu Kesehatan, 8(2), 63.
  30. Shenoy, N., Luchtel, R., & Gulani, P. (2020). Considerations for target oxygen saturation in COVID-19 patients: Are we under-shooting? BMC Medicine, 18(1), 1–6.
  31. Slattery, K. M., Dascombe, B., Wallace, L. K., Bentley, D. J., & Coutts, A. J. (2014). Effect of N-acetylcysteine on cycling performance after intensified training. Medicine and Science in Sports and Exercise, 46(6), 1114–1123.
  32. Stárka, L., & Dušková, M. (2021). Androgens in SARS-CoV-2 Coronavirus Infections. Physiological Research, 70, S145–S151.
  33. Suryati, L. T., & Juliadi, D. (2021). Gambaran Penggunaan Vitamin C Sebagai Imunomodulator Pada Pasien Dewasa Dengan Covid-19: Studi Literatur. Jurnal Farmasi & Sains Indonesia, 4(2), 31–40.
  34. Vegivinti, C. T. R., Evanson, K. W., Lyons, H., Akosman, I., Barrett, A., Hardy, N., Kane, B., Keesari, P. R., Pulakurthi, Y. S., Sheffels, E., Balasubramanian, P., Chibbar, R., Chittajallu, S., Cowie, K., Karon, J., Siegel, L., Tarchand, R., Zinn, C., Gupta, N., … Touchette, J. (2022). Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials. In BMC Infectious Diseases (Vol. 22, Issue 1). BioMed Central.
  35. Vitiello, A., & Ferrara, F. (2022). Virologi, Patogenesis, Dan Manifestasi Klinis. Immunologic Research, 70(1), 129–133.
  36. Walter, E. J., Hanna-Jumma, S., Carraretto, M., & Forni, L. (2016). The pathophysiological basis and consequences of fever. Critical Care, 20(1), 1–10.
  37. Wardani, R. S., & Anggraini, N. N. (2014). Hubungan Tingkat Pendidikan Dan Pengetahuan Dengan Perilaku Perawatan Vulva Hygiene Pada Wanita Di Lapas Semarang Tahun 2014.
  38. Widjaja, J. T., Kwee, L., Giantara, A. K., Subagiyo, H. A., Edwin, C., & Putri, R. L. (2021). Karakteristik Pasien COVID-19 Rawat Inap di RS Immanuel Bandung, Indonesia Characteristics of Inpatient Covid-19 Patients at Immanuel Hospital Bandung, Indonesia. Journal of Medicine and Health Karakteristik Pasien COVID-19 Rawat, 3(2), 164–175.
  39. Wu, S., Xue, L., Legido-Quigley, H., Khan, M., Wu, H., Peng, X., Li, X., & Li, P. (2020). Understanding factors influencing the length of hospital stay among non-severe COVID-19 patients: A retrospective cohort study in a Fangcang shelter hospital. PLoS ONE, 15(10 October), 1–14.
  40. Wu, Z., & McGoogan, J. M. (2020). Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. Jama, 323(13), 1239.
  41. Xia, T., Zhang, W., Xu, Y., Wang, B., Yuan, Z., Wu, N., Xiang, Y., Li, C., Shan, Y., Xie, W., Wang, Y., Zhang, Y., Bai, L., & Li, Y. (2021). Early kidney injury predicts disease progression in patients with COVID-19: a cohort study. BMC Infectious Diseases, 21(1), 1–11.
  42. Guidelines
  43. Xu, Y., Chen, Y., & Tang, X. (2020). Guidelines for the diagnosis and treatment of coronavirus disease 2019 (COVID-19) in China. Global Health & Medicine, 2(2), 66–72.